Vol. 4, Issue 3, 2022August 09, 2022 BST
High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens
High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens
Katrine Fladeland Iversen, Line Nederby, Thomas Lund, Torben Plesner,
Iversen, Katrine Fladeland, Line Nederby, Thomas Lund, and Torben Plesner. 2022. “High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens.” Clinical Hematology International 4 (3): 107–16. https://doi.org/10.1007/s44228-022-00013-7.